/Nelson Cabatuan/ - 07 Jan 2022 Form 4 Insider Report for Rain Therapeutics Inc.

Role
VP of Finance and Administration
Signature
/s/ Avanish Vellanki, Attorney-in-fact for Nelson Cabatuan
Issuer symbol
N/A
Transactions as of
07 Jan 2022
Net transactions value
$0
Form type
4
Filing time
04 Feb 2022, 15:45:14 UTC
Previous filing
14 May 2021
Next filing
17 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +32,000 $0.000000 32,000 07 Jan 2022 Common Stock 32,000 $12.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 32,000 shares of the Issuer's common stock, one quarter of which will vest on January 7, 2023, with the remaining three quarters vesting in equal monthly installments through January 7, 2026, subject to the Reporting Person's continued service to the Issuer.

Remarks:

VP of Finance and Administration